Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 12-2018 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,014,891 | 574,864 | 1,517,855 | -9,723 | -8,109 |
| Depreciation Amortization | 27,257 | 18,296 | 46,394 | 3 | 2 |
| Accounts receivable | 159,457 | 155,070 | N/A | N/A | N/A |
| Other Working Capital | 142,663 | 78,109 | 490,213 | 626 | 787 |
| Other Operating Activity | -155,458 | -56,562 | -436,145 | 545 | 723 |
| Operating Cash Flow | $1,188,810 | $769,777 | $1,618,317 | $-8,549 | $-6,597 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,254,523 | -1,231,736 | -269,593 | N/A | N/A |
| Purchase Of Investment | -1,147,820 | -393,801 | N/A | N/A | N/A |
| Sale Of Investment | 311,535 | 150,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 573,017 | 0 | 0 |
| Investing Cash Flow | $-2,090,808 | $-1,475,537 | $303,424 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -220,500 | -147,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 3,509 | 3,509 |
| Common Stock Repurchased | -4,228 | -4,228 | N/A | N/A | N/A |
| Dividend Paid | -681,095 | -473,907 | -1,083,052 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -296,049 | 0 | 0 |
| Financing Cash Flow | $-905,823 | $-625,135 | $-1,379,101 | $3,509 | $3,509 |
| Beginning Cash Position | 1,924,211 | 1,924,211 | 1,381,571 | 8,688 | 8,688 |
| End Cash Position | 116,390 | 593,316 | 1,924,211 | 3,648 | 5,600 |
| Net Cash Flow | $-1,807,821 | $-1,330,895 | $542,640 | $-5,040 | $-3,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,188,810 | 769,777 | 1,618,317 | -8,549 | -6,597 |
| Capital Expenditure | -1,254,523 | -1,231,736 | N/A | 0 | 0 |
| Free Cash Flow | -65,713 | -461,959 | 1,618,317 | -8,549 | -6,597 |